Skip to main content
Log in

Epidermal growth factor in plasma and saliva of patients with active breast cancer and breast cancer patients in follow-up compared with healthy women

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

We measure EGF in saliva and plasma from 52 patients with active breast cancer, 22 breast cancer patients in follow-up (non-active) and 33 healthy women. EGF concentrations in saliva were significantly higher in patients with active and non-active breast cancer than healthy women, whereas the opposite results were found in plasma. The highest values of EGF in saliva were found in the local recurrence subgroup.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. James R, Bradshaw BA: Polypeptide growth factors. Ann Rev Biochem 48: 259–289, 1979

    Google Scholar 

  2. Dickson RB, Lippman ME: Molecular determinants of growth, angiogenesis and metastases in breast cancer. Semin Oncol 19: 286–298, 1992

    Google Scholar 

  3. McKay IA: Types of growth factor activity: detection and characterization of new growth factor activities. In: McKay IA, Leigh I (eds) Growth factors, a practical approach. New York, IRL Press, 1993, pp 1–11

    Google Scholar 

  4. Green H: Terminal differentiation of cultured human epidermal cells. Cell 111: 405–410, 1977

    Google Scholar 

  5. Fisher DA, Lakshmanan J: Metabolism and effects of epidermal growth factor and related growth factors in mammals. Endocr Rev 11: 418–442, 1990

    Google Scholar 

  6. Brown CF, Teng CT, Pentecost BT et al: Epidermal growth factor precursor in mouse lactating mammary gland alveolar cells. Mol Endocrinol 3: 1077–1089, 1989

    Google Scholar 

  7. Elder JB, Williams G, Lacey E et al: Cellular localization of human urogastrone/epidermal growth factor. Nature 271: 466–467, 1978

    Google Scholar 

  8. Konturek JW, Bielanski W, Konturek SJ et al: Distribution and release of epidermal growth factor in man. Gut 30: 1194–1200, 1989

    Google Scholar 

  9. Klijn JGM, Berns PMJJ, Schmitz PIM et al.: The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: A review on 5232 patients. Endocr Rev 13: 3–17, 1992

    Google Scholar 

  10. Bolufer P, Lluch A, Molina R et al.: Epidermal growth factor in human breast cancer, endometrial cancer and lung cancer. Its relationship to epidermal growth factor receptor, estradiol receptor and tumor TNM. Clin Chim Acta 215: 51–61, 1993

    Google Scholar 

  11. Hermanek P, Sobin LH: TNM Classification of Malignant Tumours: UICC International Union Against Cancer (4th ed.). Berlin, Springer-Verlag, 1987

    Google Scholar 

  12. Smith K, Miller WR, Fennelly JA: Quantification of epidermal growth factor in human breast cyst fluids: Correlation with dehydroepiandrosterone-sulphate and electrolyte concentrations. Int J Cancer 44: 229–232, 1989

    Google Scholar 

  13. Papaioannou AN: Hypothesis: Increasingly intensive locoregional treatment of breast cancer may promote recurrence. J Surg Oncol 30: 33–41, 1985

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Navarro, M.A., Mesía, R., Díez-Gibert, O. et al. Epidermal growth factor in plasma and saliva of patients with active breast cancer and breast cancer patients in follow-up compared with healthy women. Breast Cancer Res Treat 42, 83–86 (1997). https://doi.org/10.1023/A:1005755928831

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005755928831

Navigation